How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Close this folder2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contentsOrganization of the national formulary committee
View the documentAgreement on purpose, content, structure and format
View the documentFinancing
View the documentSelection of medicines to be included in the national formulary
View the documentDevelopment of the draft
View the documentReviewing and finalizing content
View the documentProduction, dissemination and implementation
View the documentEvaluation and review
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Reviewing and finalizing content

The review and finalization of the content of the NFC takes into account the input of various expert advisers and their consolidated comments, before agreement is reached on the final draft. The credibility and authority of the NF depend heavily on this consultation process, which will affect the acceptance and potential impact of the NF. Reaching consensus on the final text can be a lengthy process and it is important to use the most effective means of communication, follow-up meetings or workshops to avoid delays.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014